ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 189 filers reported holding ANI PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $266,437 | +18.6% | 4,589 | +9.9% | 0.00% | 0.0% |
Q2 2023 | $224,686 | -41.3% | 4,174 | -32.7% | 0.00% | -60.0% |
Q4 2019 | $383,000 | -51.9% | 6,203 | -43.2% | 0.01% | -50.0% |
Q3 2019 | $796,000 | -25.9% | 10,919 | -16.5% | 0.01% | -16.7% |
Q2 2019 | $1,074,000 | +18.9% | 13,070 | +2.1% | 0.01% | +9.1% |
Q1 2019 | $903,000 | +57.0% | 12,797 | +0.2% | 0.01% | +57.1% |
Q4 2018 | $575,000 | -15.3% | 12,771 | +6.4% | 0.01% | +16.7% |
Q3 2018 | $679,000 | -22.8% | 12,001 | -8.8% | 0.01% | -33.3% |
Q2 2018 | $879,000 | +6.7% | 13,166 | -7.0% | 0.01% | +12.5% |
Q1 2018 | $824,000 | -15.1% | 14,161 | -6.0% | 0.01% | -11.1% |
Q4 2017 | $971,000 | +301.2% | 15,061 | +226.3% | 0.01% | +200.0% |
Q3 2017 | $242,000 | +18.6% | 4,615 | +12.2% | 0.00% | 0.0% |
Q1 2017 | $204,000 | -18.1% | 4,115 | 0.0% | 0.00% | -25.0% |
Q4 2016 | $249,000 | -8.8% | 4,115 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $273,000 | +24.7% | 4,115 | +5.1% | 0.00% | +33.3% |
Q2 2016 | $219,000 | – | 3,915 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Capital Management, Inc | 73 | $4,025 | 0.00% |